- ISIN US9902131674
Latest News
News Functions
Additional Functions
4 November 2014
myoscience
Jeffrey Gold neuer Chief Executive Officer von myoscience
3 November 2014
myoscience
Jeffrey Gold Appointed Chief Executive Officer of myoscience
1 October 2014
myoscience
Neuer Meilenstein für die iovera-Schönheitsbehandlung
myoscience
Next Advancement for the iovera Beauty Treatment
6 August 2014
myoscience
Justin Chickles Joins myoscience as Vice President of Commercial Development & Johanna Beckmen Becomes General Manager of Aesthetics
myoscience
Justin Chickles Joins myoscience as Vice President of Commercial Development & Johanna Beckmen Becomes General Manager of Aesthetics
22 May 2014
myoscience
myoscience Named Winner of the 2014 Red Herring Top 100 North America Award
myoscience
myoscience Named Winner of the 2014 Red Herring Top 100 North America Award
7 May 2014
myoscience
myoscience, inc. is a Finalist for the 2014 Red Herring Top 100 North America Award
myoscience
myoscience, inc. is a Finalist for the 2014 Red Herring Top 100 North America Award
1 May 2014
myoscience
Novel Pain Treatment is Now Available: iovera System Harnesses the Power of Cold to Block Pain
myoscience
Novel Pain Treatment is Now Available: iovera System Harnesses the Power of Cold to Block Pain
23 April 2014
myoscience
Jeffrey Gold Joins myoscience as President and Chief Operating Officer
myoscience
Jeffrey Gold Joins myoscience as President and Chief Operating Officer
25 February 2014
myoscience
Myoscience to Present at the Canaccord Genuity Musculoskeletal Conference
myoscience
Myoscience to Present at the Canaccord Genuity Musculoskeletal Conference
7 January 2014
myoscience
iovera Wins Good Design Award
myoscience
iovera Wins Good Design Award
21 November 2013
myoscience
myoscience to Present at the Piper Jaffray 25th Annual Health Care Conference
myoscience
myoscience to Present at the Piper Jaffray 25th Annual Health Care Conference
20 November 2013
myoscience
iovera Wins Spark Design Award
myoscience
iovera Wins Spark Design Award
17 September 2013
myoscience
iovera Treatment for Dynamic Wrinkles Now Offered by Drs. Jean & Alastair Carruthers and Doctor Shannon Humphrey
myoscience
iovera Treatment for Dynamic Wrinkles Now Offered by Drs. Jean & Alastair Carruthers and Doctor Shannon Humphrey
16 September 2013
myoscience
Peter Osborne Joins myoscience as Chief Financial Officer
myoscience
Peter Osborne Joins myoscience as Chief Financial Officer
12 September 2013
myoscience
myoscience Announces $25 Million Series E Financing Round
myoscience
myoscience Announces $25 Million Series E Financing Round
18 July 2013
myoscience
iovera Treatment for Dynamic Wrinkles Now Approved in Canada
myoscience
iovera Treatment for Dynamic Wrinkles Now Approved in Canada